Corestate Capital (CCAP) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
25 Aug, 2026Executive summary
Asset disposal program proceeds for 2026 revised down from €61.8m to €46.5m due to timing shifts and price adjustments.
Proceeds for 2027 increased by €4.6m to €69.3m, mainly from postponed sales.
Total expected proceeds through 2027 decreased by €10.7m (4.8%) to €212.3m.
Partial redemption of Super Senior Notes in July 2026 amounted to €4.8m; further August redemption canceled.
Full repayment of remaining €22.7m Super Senior Notes now planned for end of 2026.
Financial highlights
€11.1m received from Giessen in Q2 2026 and €2.1m in Q3; €6.6m from other financial instruments in Q3.
2023 and 2024 asset sales totaled €29.3m and €38.9m, respectively.
2025 sales declined to €28.3m due to legal disputes and project postponements.
Outlook and guidance
Asset disposal program continues with focus on value preservation and debt repayment.
Liquidity forecast shows repayment plans remain on track despite timing shifts.
Latest events from Corestate Capital
- Deleveraging and asset disposals drive Q1 2026, with losses widening and AUM declining.CCAP
Q1 2026 - Revenue and EBITDA rebounded, with asset disposals and debt extension supporting stabilization.CCAP
Q4 2025 - Significant losses and deleveraging mark a challenging transition to a holding structure.CCAP
Q3 2025 - Revenue and EBITDA fell, but asset sales and liquidity support ongoing deleveraging.CCAP
Q2 2025 - Revenue up, profits down; asset sales and debt repayment drive 2025 strategy.CCAP
Q1 2025 - Net loss, lower equity, and delayed asset sales mark Corestate's ongoing restructuring.CCAP
Q3 2024 - EBITDA loss narrowed and asset sales accelerated, but AUM and equity ratio declined.CCAP
Q2 2024 - Losses narrowed and asset sales progressed, but liquidity remains a key challenge.CCAP
Q1 2024 - Restructuring nearly complete; focus shifts to asset sales and deleveraging amid market headwinds.CCAP
Q4 2024